Home1JK • FRA
add
Apellis Pharmaceuticals Inc
Previous close
€33.55
Day range
€33.98 - €33.98
Year range
€19.00 - €78.00
Market cap
4.56B USD
Avg Volume
20.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 172.32M | 284.26% |
Operating expense | 129.50M | 26.85% |
Net income | -66.42M | 62.64% |
Net profit margin | -38.55 | 90.28% |
Earnings per share | -0.54 | 65.38% |
EBITDA | -61.65M | 64.71% |
Effective tax rate | -0.26% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 333.54M | -56.91% |
Total assets | 831.93M | -15.01% |
Total liabilities | 565.25M | -0.26% |
Total equity | 266.68M | — |
Shares outstanding | 121.37M | — |
Price to book | 15.25 | — |
Return on assets | -19.16% | — |
Return on capital | -45.57% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -66.42M | 62.64% |
Cash from operations | -132.98M | 25.13% |
Cash from investing | -293.00K | -13.13% |
Cash from financing | 108.21M | -72.33% |
Net change in cash | -25.27M | -111.85% |
Free cash flow | -111.80M | 16.04% |
About
Founded
2009
Headquarters
Website
Employees
704